| Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer (NCT05437692) | Shanghai Zhongshan Hospital | 2022-07-15 |
| Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer (NCT05378087) | Chongqing University Cancer Hospital | 2022-06-27 |
| Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer (NCT05717751) | Chongqing University Cancer Hospital | 2022-04-13 |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer (NCT05311566) | Lei Li | 2022-03-27 |
| A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer (NCT05779111) | Chongqing University Cancer Hospital | 2022-02-10 |
| MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer (NCT03977311) | Washington University School of Medicine | 2021-12-31 |
| Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer (NCT04238988) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-02-18 |
| Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer (NCT04884906) | Tianjin Medical University Cancer Institute and Hospital | 2020-11-01 |
| Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients (NCT05059119) | Far Eastern Memorial Hospital | 2020-09-01 |
| Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study (NCT05746156) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-07-20 |
| Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer (NCT06156514) | National Institute of Cancerología | 2019-11-06 |
| NAC Followed by RH for the Treatment of LACC (NCT03963882) | Lei Li | 2019-06-19 |
| Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (NCT03830866) | AstraZeneca | 2019-02-15 |
| Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab (NCT03612791) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-08-13 |
| Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL) (NCT03298893) | Institut Curie | 2017-11-27 |
| Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy (NCT03225443) | Shanghai First Maternity and Infant Hospital | 2017-09-30 |
| Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer (NCT02045433) | University of Texas Southwestern Medical Center | 2014-03-27 |
| Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer (NCT01938105) | People's Hospital of Guangxi Zhuang Autonomous Region | 2013-07-01 |
| A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer (NCT01217177) | Novartis Pharmaceuticals | 2011-12-01 |
| Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer (NCT01230996) | Barts & The London NHS Trust | 2010-07-01 |
| An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer (NCT01514955) | AHS Cancer Control Alberta | 2009-11-01 |
| Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer (NCT00548821) | National University Hospital, Singapore | |